A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer Patients
NCT ID: NCT00188305
Last Updated: 2015-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
252 participants
INTERVENTIONAL
2005-01-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Do Patients With Colorectal Cancer Understand That Their Family is at Risk?
NCT00145860
Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer
NCT00352638
Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer
NCT01903395
Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients
NCT00838318
Identification of High Risk People for Colorectal Cancer and Evaluation of a Specific Surveillance System
NCT02931825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 In person
In person general health, colorectal cancer risk information and screening recommendations.
General health counselling and risk information
General health counselling and risk information
2 Telephone
Telephone general health counselling, colorectal cancer risk information and screening recommendations.
General health counselling and risk information
General health counselling and risk information
3 Control
Standard care for 2 months followed by summary letter with general health information, colorectal cancer risk information and screening recommendations.
General health counselling and risk information
General health counselling and risk information
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
General health counselling and risk information
General health counselling and risk information
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be between the ages of 25 and 65 years
* live within one hour of Toronto
Exclusion Criteria
* family history suggestive of hereditary Colorectal Cancer
* history of major psychiatric disorder (i.e. schizophrenia, active psychosis, major depression)
* failure to provide consent.
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary Jane Esplen, PhD
Role: PRINCIPAL_INVESTIGATOR
University Health Network, Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Sciences Centre, Memorial University
St. John's, Newfoundland and Labrador, Canada
University Health Network
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UHN04-0729-CE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.